- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.05. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.04. | Procaps Group, S.A.: Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership | 83 | GlobeNewswire (Europe) | New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates... ► Artikel lesen | |
| 09.04. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| PROCAPS GROUP Aktie jetzt für 0€ handeln | |||||
| 25.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 06.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 19.02. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.02.2025 | 1.354 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.02.2025ISIN NameCA00208E3077 ATI... ► Artikel lesen | |
| 04.02. | Nasdaq delists Colombia's Procaps Group due to financial shortfalls | 1 | iNVEZZ.com | ||
| 04.02. | XFRA 9X1: AUSSETZUNG/SUSPENSION | 318 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROCAPS GRP S.A.... ► Artikel lesen | |
| 03.02. | Procaps Group, S.A.: Procaps Group Receives Delisting Notice From Nasdaq | 374 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 03.02. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.01. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.01. | Procaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter | 303 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 31.12.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 20.12.24 | Procaps Group announces newly appointed board members, CFO transition | 2 | Seeking Alpha | ||
| 20.12.24 | Procaps Group, S.A.: Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates | 302 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 20.12.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 03.12.24 | Procaps Group, S.A.: Procaps Group Announces Financing, Shareholders Agreement and Board Updates | 209 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 29.11.24 | Pre-market Movers: Bolt Projects, Applied Therapeutics, Primega Group, Procaps Group, SKK Holdings | 979 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.25 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 233%... ► Artikel lesen | |
| 16.11.24 | Procaps Group, S.A.: Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing | 334 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 5,030 | +0,20 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
| CANOPY GROWTH | 1,498 | +0,67 % | Nach zuletzt starken Gewinnen: Erwartung verfehlt: Crasht jetzt die Aktie von Canopy Growth? | © Foto: Dall-EDer kanadische Cannabiskonzern Canopy Growth hat mit seinen am Freitagmittag vorgelegten Quartalszahlen die Erwartungen der Analysten nicht erfüllen können.In den vergangenen Wochen ist... ► Artikel lesen | |
| TILRAY BRANDS | 0,357 | +0,11 % | Tilray Unveils Bold Summer Craft Beer Lineup Across Iconic Breweries | ||
| TEVA | 15,250 | -2,24 % | Teva Pharmaceutical: Teva 2024 Healthy Future Report: Health System Strengthening and Capacity Building | NORTHAMPTON, MA / ACCESS Newswire / June 6, 2025 / Teva Pharmaceutical:At Teva, we are all in for better health. Increasing access to quality medicines is fundamental to improving the health of patients... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 395,50 | +0,08 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on Benefits of ALYFTREK and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference | - Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with... ► Artikel lesen | |
| ARZNEIWERK AG VIDA | 0,695 | +10,32 % | PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Arzneiwerk... ► Artikel lesen | |
| CRONOS GROUP | 1,728 | -0,80 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
| VIATRIS | 7,584 | -0,73 % | Viatris Reports Positive Top-line Results From LYNX-2 Phase 3 Trial With MR-142 | WASHINGTON (dpa-AFX) - Viatris (VTRS) reported positive top-line results from LYNX-2, a Phase 3 trial evaluating MR-142 in treating significant, chronic night driving impairment in keratorefractive... ► Artikel lesen | |
| INCYTE | 58,90 | -2,42 % | Incyte kündigt mehrere Präsentationen an, darunter neue aktuelle Daten zu seinem mutCALR-gerichteten monoklonalen Antikörper (INCA033989), die zur Präsentation auf der EHA 2025 angenommen wurden | In einer Late-Breaking mündlichen Präsentation werden neue Daten aus einer Studie mit INCA033989 vorgestellt, einem gegen mutiertes Calreticulin (mutCALR) gerichteten monoklonalen Antikörper... ► Artikel lesen | |
| BAUSCH HEALTH | 4,220 | +1,15 % | Bausch Health Companies Inc: Bausch Health Announces 2025 Annual Meeting of Shareholder Results | LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 30,650 | +0,46 % | Ionis Pharmaceuticals, Inc.: Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. | - Agreement enables olezarsen to reach people living with conditions associated with elevated triglycerides across the world - - Ionis will continue to independently commercialize TRYNGOLZA (olezarsen)... ► Artikel lesen | |
| CRESCO LABS | 0,496 | +1,85 % | Canaccord Genuity stuft Cresco Labs-Aktie aufgrund von Wettbewerbsdruck herab | ||
| ALNYLAM PHARMACEUTICALS | 270,30 | +2,35 % | Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case | ||
| NEKTAR THERAPEUTICS | 0,602 | +3,35 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS0977021049 Bolt Biotherapeutics Inc. 06.06.2025 US0977022039 Bolt Biotherapeutics Inc. 09.06.2025 Tausch 20:1SE0018041097 Spotr... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 1,910 | -2,20 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen |
Das Unternehmen PROCAPS GROUP SA kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROCAPS GROUP SA finden Sie auf Wallstreet Online.